London, United Kingdom

Peter John Sprada

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Serono S. a.. Active years: 2014.



 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Peter John Sprada

Introduction

Peter John Sprada is a notable inventor based in London, GB. He has made significant contributions to the field of medication safety, particularly with his innovative designs aimed at protecting children from accidental ingestion of medications. His work exemplifies the importance of safety in pharmaceutical packaging.

Latest Patents

Peter holds a patent for a child-resistant medication container. This invention is designed to prevent children from easily accessing potentially harmful medications, thereby enhancing safety in households with young children. The patent reflects his commitment to public health and safety.

Career Highlights

Peter is currently employed at Merck Serono S.A., a leading global biopharmaceutical company. His role at Merck Serono allows him to work on cutting-edge pharmaceutical innovations that aim to improve patient care and safety. His expertise in medication safety has been instrumental in the development of new products.

Collaborations

Peter has collaborated with Robert Prasser, a fellow innovator in the field. Together, they have worked on projects that focus on enhancing the safety and efficacy of medication delivery systems. Their partnership highlights the importance of teamwork in driving innovation.

Conclusion

Peter John Sprada's contributions to the field of medication safety through his patent for a child-resistant medication container demonstrate his dedication to protecting children and improving public health. His work at Merck Serono S.A. further emphasizes the impact of innovative thinking in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…